Clinical Trials Browser

INDUSTRY × icotinib × Gastrointestinal × Clear all

NCT01855854 2019-07-05

Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT02278458 2015-05-22

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms